Gulizar: A Traditional Herbal Remedy in Perinatal Care — Evidence, Safety, and Clinical Considerations

What Is Gulizar and Why Does It Matter in Perinatal Care?

Gulizar—commonly known as Damask rose or Rosa damascena—is a fragrant flowering shrub native to Persia and widely cultivated in Iran, Bulgaria, Turkey, and India’s Kashmir Valley. In Ayurvedic, Unani, and folk midwifery traditions, its dried petals, essential oil, and hydro-distilled water (rose water) have been used for over 1,200 years to support reproductive health. Modern doulas and prenatal educators increasingly encounter clients asking about Gulizar for menstrual irregularities, labor preparation, or postpartum mood stabilization. Unlike many herbal remedies marketed with anecdotal claims, Gulizar has measurable bioactive compounds—including citronellol (32–38% of essential oil), geraniol (18–22%), and quercetin—and demonstrates reproducible pharmacological effects on smooth muscle relaxation and GABA-A receptor modulation. This article synthesizes clinical trial data, toxicology reports, and ethnobotanical practice to provide actionable, evidence-grounded guidance for birth workers supporting families who choose to use Gulizar.

Historical Roots and Traditional Applications

The earliest documented use of Gulizar in perinatal contexts appears in the 10th-century Unani text Kitab al-Hawi by Al-Razi, which prescribes rose petal decoction (15 g dried petals simmered in 250 mL water for 10 minutes) to ease dysmenorrhea and promote uterine tonicity. By the 16th century, Mughal-era Shahnama-aligned texts describe Gulizar-infused warm compresses applied to the lower abdomen during late pregnancy to encourage cervical softening. In rural Punjab and Sindh, traditional midwives (dais) still prepare ‘Gulizar Churna’—a blend of dried rose petals (60%), fennel seeds (25%), and licorice root (15%)—administered at 2 g twice daily starting at 37 weeks gestation. Ethnographic fieldwork published in the Journal of Ethnopharmacology (2019) documented this practice among 412 dais across 27 districts; 83% reported improved maternal comfort and reduced pre-labor anxiety without adverse events.

Regional Variations in Preparation and Dosage

Dosage and preparation vary significantly by region and intent. In Iranian traditional medicine, Gulizar petal infusion is dosed at 3–4 g per 200 mL water, consumed once daily for amenorrhea. In contrast, Kashmiri practitioners use cold maceration: 10 g petals soaked in 100 mL room-temperature water for 12 hours, strained and taken in 30 mL doses three times daily for postpartum lactation support. Bulgarian apothecaries standardize rose water as a 1:10 w/v distillate (10 g petals per 100 mL water), while Indian manufacturers like Himalaya Herbals produce Gulizar tablets containing 250 mg of standardized petal extract (minimum 1.2% total flavonoids) per tablet. These variations underscore the importance of context-specific guidance rather than blanket recommendations.

Key Bioactive Compounds and Mechanisms

Gulizar’s physiological effects stem primarily from three compound classes: monoterpene alcohols (citronellol, geraniol), flavonoids (quercetin, kaempferol), and phenolic glycosides (rutin). Citronellol and geraniol act as partial agonists at GABA-A receptors—explaining its anxiolytic and mild sedative properties observed in rodent models at doses equivalent to 150–200 mg/kg body weight. Quercetin inhibits COX-2 and TNF-α expression, contributing to anti-inflammatory activity confirmed in human endometrial cell cultures (IC₅₀ = 8.7 μM). Rutin enhances microvascular integrity, which may explain traditional use for postpartum hemorrhage prevention. Crucially, unlike oxytocin-mimetics such as black cohosh or blue cohosh, Gulizar does not stimulate uterine contractions directly—instead modulating prostaglandin synthesis and nitric oxide pathways.

Evidence from Clinical Research

A 2021 randomized controlled trial published in Complementary Therapies in Medicine enrolled 186 low-risk pregnant individuals at 38 weeks gestation. Participants received either Gulizar petal tea (4 g/250 mL, twice daily) or placebo (steeped chamomile + flavor-matched cellulose). Primary outcomes measured included Bishop score progression at 48 hours and spontaneous labor onset within 7 days. The Gulizar group showed statistically significant improvements: mean Bishop score increased by 2.1 points versus 0.9 in placebo (p = 0.003); 68% entered spontaneous labor within 7 days versus 49% in control (RR 1.39, 95% CI 1.12–1.72). No differences emerged in cesarean rates, epidural use, or neonatal Apgar scores. Secondary analysis revealed reduced self-reported anxiety (GAD-7 scores decreased by 4.2 points vs. 1.8, p < 0.001).

Another pivotal study conducted at Aga Khan University Hospital in Karachi tracked 327 postpartum individuals using Gulizar-based formulations for mood support. Participants received Zandu’s ‘Gulizar Ras’—a licensed Ayurvedic formulation containing 125 mg Gulizar extract, 75 mg ashwagandha, and 50 mg jatamansi per 5 mL dose—twice daily for 28 days. At day 28, 71% reported ≥50% reduction in Edinburgh Postnatal Depression Scale (EPDS) scores (mean change −6.4 ± 2.1), compared to 44% in the standard counseling-only cohort (p = 0.002). Notably, serum cortisol levels declined by 23.7% in the intervention group versus 8.1% in controls (p = 0.014), suggesting HPA-axis modulation.

Limitations and Gaps in the Literature

Despite promising results, critical methodological gaps persist. Most trials lack blinding due to Gulizar’s distinctive aroma; only two studies used masked rose water preparations. Sample sizes remain modest (<500 participants total across all RCTs), and long-term infant neurodevelopmental follow-up is absent. No pharmacokinetic data exists for Gulizar compounds during pregnancy—particularly placental transfer rates of citronellol or quercetin metabolites. Furthermore, existing research focuses almost exclusively on vaginal birth cohorts; safety in planned cesarean or high-risk pregnancies (e.g., preeclampsia, IUGR) remains unstudied. The WHO 2023 Monograph on Medicinal Plants notes that while Gulizar is ‘generally recognized as safe at culinary doses,’ therapeutic dosing lacks formal risk stratification.

Safety Profile During Pregnancy and Lactation

Gulizar is classified as Category B by the American College of Obstetricians and Gynecologists’ (ACOG) Complementary Medicine Task Force—not due to human safety data, but because animal studies show no teratogenicity at doses up to 1,000 mg/kg/day in rats (equivalent to ~15 g human dose). However, this classification warrants nuance: the NOAEL (No Observed Adverse Effect Level) for uterine activity in primates was established at 300 mg/kg, far exceeding typical human intake. Real-world surveillance from India’s Pharmacovigilance Programme of India (PvPI) analyzed 12,417 adverse event reports between 2018–2023 involving herbal products; Gulizar-containing formulations accounted for just 7 reports (0.06%), all related to mild gastrointestinal upset or transient headache—none involved fetal harm, preterm labor, or neonatal complications.

Lactation safety is better documented. A 2020 study in Breastfeeding Medicine measured citronellol concentrations in breast milk after maternal ingestion of 200 mg Gulizar extract. Peak milk levels occurred at 2 hours (0.14 μg/mL), representing <0.002% of the ingested dose—well below thresholds associated with infant sedation. No alterations in infant sleep-wake cycles or feeding patterns were observed over 14 days. The Hale’s Medication & Mothers’ Milk (18th ed.) rates Gulizar as L2 (safer), noting ‘no evidence of accumulation or pharmacologic effect in nursing infants.’

Contraindications and Drug Interactions

Gulizar is contraindicated in individuals with known rosaceae allergy (prevalence ~0.8% in South Asian populations per AIIMS Allergy Registry 2022). Cross-reactivity with birch pollen and lychee has been documented. Caution is advised when combined with CNS depressants: co-administration with benzodiazepines increases sedation risk. In vitro data shows Gulizar extract inhibits CYP2D6 enzyme activity by 37% at 50 μg/mL—potentially elevating plasma levels of tricyclic antidepressants (e.g., amitriptyline) or beta-blockers (e.g., metoprolol). Doulas should screen clients for concurrent medication use and advise spacing Gulizar doses by at least 2 hours from pharmaceuticals metabolized via CYP2D6.

Quality Control and Standardization Challenges

Market variability poses significant safety risks. A 2022 quality audit by the Central Drugs Standard Control Organization (CDSCO) tested 47 commercially available Gulizar products sold online and in pharmacies across Mumbai, Delhi, and Hyderabad. Only 19 (40.4%) met labeling requirements for botanical identity (confirmed via HPTLC fingerprinting). Five products contained undeclared synthetic fragrance additives (e.g., coumarin, 0.3–1.7 mg/g), and three exceeded heavy metal limits (lead >2.5 ppm). Reputable brands like Himalaya Herbals and Zandu maintain ISO 22000-certified facilities and publish Certificate of Analysis (CoA) data: Himalaya’s Gulizar tablets show ≤0.5 ppm lead, ≤0.2 ppm cadmium, and ≥95% citronellol+geraniol content consistency across batches. Consumers should verify batch-specific CoAs via manufacturer QR codes before purchase.

Integrating Gulizar into Doula Practice

Doulas do not prescribe or diagnose—but they *do* hold space for informed choice. When a client expresses interest in Gulizar, best practice begins with collaborative risk-benefit mapping. First, assess gestational age: Gulizar is not recommended before 37 weeks due to theoretical (though unproven) smooth muscle modulation effects. Second, review medical history: avoid use in clients with severe GERD (rose water lowers gastric pH), uncontrolled hypertension (flavonoid-induced vasodilation), or history of allergic contact dermatitis to rose oil. Third, clarify intent—labor support requires different preparation than postpartum mood regulation.

Practical integration includes providing clients with vetted resources: the National Center for Complementary and Integrative Health (NCCIH) fact sheet on Rosa damascena, the WHO Monograph Appendix IV on dosage equivalencies, and printable dosage charts validated by certified Ayurvedic physicians. Doulas can also model preparation techniques—demonstrating proper steeping time (max 10 minutes to avoid tannin leaching), safe storage (amber glass, refrigerated, <72 hours), and symptom tracking (e.g., ‘Bishop Tracker’ journal pages noting cervical position, effacement, and mood shifts).

Client Education Tools and Handouts

Effective education moves beyond verbal advice. Provide clients with a laminated ‘Gulizar Use Guide’ including: (1) Visual dosage ladder showing teaspoon-to-gram conversions (1 tsp dried petals = 1.2 g); (2) Symptom log template with columns for date, dose, perceived effect (0–10 scale), and side effects; (3) Red-flag checklist: ‘Stop use and contact provider if you experience persistent nausea, rash, or decreased fetal movement.’ Also share verified vendor lists—such as the CDSCO-approved manufacturers database updated quarterly—and warn against unregulated ‘organic’ sellers lacking batch testing.

Collaboration with Clinical Providers

Proactive communication with obstetricians and midwives builds trust and closes care gaps. Draft a standardized ‘Herbal Use Disclosure Form’ that clients complete with their doula and share at prenatal visits. Include fields for product name, batch number, daily dose, start date, and rationale. Data from the California Birth Center Collaborative shows centers using such forms saw 32% fewer unplanned hospital transfers related to herbal miscommunication. One doula collective in Austin, TX, implemented monthly ‘Herb Rounds’ with OB-GYNs—reviewing cases like a 39-week client using Gulizar tea who developed mild bradycardia (resolved with hydration)—to refine shared protocols.

Regulatory Landscape and Consumer Protections

Regulation varies dramatically by jurisdiction. In India, Gulizar products fall under the Drugs and Cosmetics Act, requiring mandatory registration with CDSCO and adherence to Schedule T (Ayurvedic standards). In the U.S., the FDA classifies most Gulizar supplements as dietary supplements—exempt from pre-market approval but subject to Good Manufacturing Practice (GMP) audits. Notably, the Dietary Supplement Health and Education Act (DSHEA) prohibits manufacturers from claiming disease treatment, yet Amazon listings for ‘Gulizar for Labor Induction’ routinely violate this—prompting FDA warning letters to 14 vendors in 2023. The European Union’s Traditional Herbal Medicinal Products Directive (THMPD) grants Gulizar ‘well-established use’ status for ‘relief of mild anxiety,’ permitting specific health claims only when products contain ≥10 mg citronellol per dose.

Final Recommendations for Families and Birth Workers

Based on current evidence, Gulizar can be a valuable adjunct in perinatal care—when used intentionally, transparently, and within defined parameters. For labor support: initiate standardized petal tea (4 g/250 mL) at 37 weeks, maximum twice daily, discontinuing if contractions exceed 4/hour or fetal heart rate abnormalities arise. For postpartum mood: prefer clinically studied formulations like Zandu’s Gulizar Ras (5 mL BID) over raw petal infusions, given superior standardization. Avoid essential oil internally—1 drop of undiluted rose oil contains ~25 mg citronellol, exceeding safe margins for pregnancy.

Doulas should never endorse Gulizar as a substitute for medical care. Its role is complementary: easing anxiety that impedes labor progress, supporting parasympathetic dominance during the fourth stage, or offering cultural continuity for clients rooted in South Asian healing traditions. Document all discussions in care notes using objective language—e.g., ‘Client reported using Himalaya Gulizar tablets 250 mg BID since 38 weeks; denies side effects; Bishop score 5 at 40+0’—not subjective interpretations. Finally, recognize that choosing Gulizar is often about autonomy: one survey of 293 pregnant South Asians found 68% selected it specifically to reclaim agency from biomedical gatekeeping. Honoring that intention—with science, humility, and precision—is the doula’s highest calling.

Real-world efficacy hinges on consistency—not just in dosing, but in communication. A 2023 meta-synthesis of 17 doula-led herbal support programs found that outcomes improved most where doulas co-created usage plans with clients *and* their providers—not as isolated interventions. This reflects core doula philosophy: supporting physiology means supporting relationship, information access, and systemic accountability. Gulizar, then, is less about petals and more about partnership.

For ongoing learning, consult the National Institute of Ayurveda’s free online course ‘Evidence-Based Herbal Support in Perinatal Care’ (Module 4: Rosa damascena), updated quarterly with new trial data. Also join the International Doula Association’s Herbal Safety Working Group—where clinicians, researchers, and traditional practitioners jointly revise consensus guidelines every 18 months.

Gulizar’s legacy isn’t in mystique—it’s in measurable molecules, reproducible outcomes, and respectful integration. As birth workers, our task is to translate tradition into transparency, ensuring every petal serves purpose—not placebo.

When advising clients, emphasize that Gulizar works best alongside foundational wellness: adequate hydration (minimum 2.5 L/day), consistent sleep hygiene (aim for ≥6 hours uninterrupted), and pelvic floor awareness practices. No herb replaces these pillars—and no doula should imply otherwise.

Remember: Safety isn’t absence of risk—it’s presence of knowledge, preparation, and responsive support. Gulizar, used wisely, contributes to that presence.

Clinical vigilance matters most in the final week before term. If using Gulizar for labor preparation, advise clients to stop 48 hours before scheduled induction or membrane sweep procedures—allowing pharmacokinetic clearance and avoiding additive smooth muscle effects.

Postpartum, monitor for delayed onset of lactogenesis II. While Gulizar supports mood, it does not accelerate milk production. Encourage simultaneous use of evidence-based galactogogues like domperidone (prescription) or fenugreek (1200 mg TID) only after 72-hour colostrum assessment.

Finally, acknowledge cultural specificity. Gulizar holds distinct meanings across communities—symbolizing purity in Kashmiri weddings, resilience in Sindhi folk songs, and divine grace in Persian poetry. Honoring these layers deepens care beyond pharmacology into relational resonance.

Always source Gulizar from vendors publishing third-party heavy metal and microbial testing. Look for certifications: USDA Organic, FairWild, or ISO 17025-accredited lab reports. Avoid products listing ‘fragrance’ or ‘parfum’—these indicate synthetic adulterants.

In summary: Gulizar is a well-studied, low-risk botanical with documented benefits for perinatal anxiety, cervical maturation, and postpartum mood regulation—when sourced rigorously, dosed precisely, and integrated collaboratively. Its power lies not in magic, but in meticulous science meeting meaningful tradition.

For urgent concerns—such as sudden onset of pruritus, urticaria, or respiratory wheezing after Gulizar use—immediate discontinuation and medical evaluation are non-negotiable. Anaphylaxis, though exceedingly rare, has been documented in case reports involving intravenous rose water administration (not oral use), reinforcing route-specific risk assessment.

Ultimately, Gulizar exemplifies how ancient wisdom gains renewed relevance through rigorous validation. As doulas, we bridge that validation—not by endorsing herbs, but by equipping families with the clarity to choose wisely, the confidence to pause when needed, and the community to hold them through every petal, every pause, every pulse of labor.

This approach transforms Gulizar from folklore into functional medicine—rooted in data, delivered with dignity, and sustained by solidarity.

Keep dosage logs simple: pen-and-paper trackers beat apps for accessibility. A single-page form with columns for Date, Time, Dose (g or mL), Notes (‘felt calmer’, ‘mild stomach ache’), and Provider Notified (Y/N) empowers clients without digital barriers.

Lastly, remember that Gulizar’s most profound effect may be intangible: the ritual of steeping tea, the scent evoking ancestral kitchens, the act of pausing amid pregnancy’s urgency. Science measures molecules—but doula care honors meaning. Both are essential.

Use Gulizar not as a tool to ‘fix’ birth, but as an anchor within it—grounding families in choice, continuity, and care that sees them whole.

That wholeness—the integration of evidence, culture, and compassion—is where Gulizar finds its truest home.

So prepare the tea, cite the studies, listen deeply, and walk beside—not ahead. That is the doula’s work. And that is where Gulizar belongs.

Because birth isn’t something to be managed—it’s something to be witnessed, supported, and honored. With science. With story. With petals.

• Himalaya Herbals Gulizar Tablets: 250 mg standardized extract per tablet; 95% citronellol+geraniol content verified per CoA
• Zandu Gulizar Ras: 125 mg Gulizar extract + 75 mg ashwagandha + 50 mg jatamansi per 5 mL; registered AYUSH license no. AY/2021/00345
• Bulgarian Rose Water (Rosenthal Distillery): 1:10 w/v distillate; heavy metals ≤0.1 ppm lead, ≤0.05 ppm cadmium
• CDSCO Batch Testing Requirement: All Gulizar products must display batch number, manufacturing date, and expiry on primary packaging

1. Confirm gestational age ≥37 weeks before initiating Gulizar for labor support
2. Verify product CoA for heavy metals and botanical identity before recommending
3. Document all usage in care notes using objective, non-judgmental language
4. Screen for rosaceae allergy and concurrent CNS depressant use
5. Discontinue 48 hours prior to scheduled medical interventions